Brar R, Grant C, DeBeck K, Milloy MJ, Fairbairn N, Wood E, Kerr T, Hayashi K Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada Am J Drug Alcohol Abuse, 2020. PubMed
Ickowicz S, Brar R, Nolan S Case study: naltrexone for the treatment of nitrous oxide use J Addict Med, 2020. PubMed
Lowik AJ, Hoong P, Knight R Where is the science? A critical interrogation of how sex and gender are used to inform low-risk alcohol use guidelines J Addict Med, 2020. PubMed
Ickowicz S, Grant C, Nosova E, Boyd J, Brar R, Milloy MJ, Hayashi K, Nolan S Factors associated with the use of supervised consumption facilities among women who inject drugs in a Canadian setting J Addict Med, 2020. PubMed
Giang V, Brar R, Sutherland C, Nolan S HIV treatment initiation and retention among individuals initiated on injectable opioid agonist therapy for severe opioid use disorder: a case series J Addict Med, 2020. PubMed
Reddon H, Kerr T, Milloy MJ Ranking evidence in substance use and addiction Int J Drug Policy, 2020. PubMed
Mitra S, Boyd J, Wood E, Grant C, Milloy MJ, DeBeck K, Kerr T, Hayashi K Elevated prevalence of self-reported unintentional exposure to fentanyl among women who use drugs in a Canadian setting: a cross-sectional analysis Int J Drug Policy, 2020. PubMed
Tobias S, Shapiro A, Wu H, Ti L Xylazine identified in the unregulated drug supply in British Columbia, Canada Can J Addict, 2020. Link
Mackay L, Ickowicz S, Hayashi K, Abrahams R Rooming-in and loss of child custody: key factors in maternal overdose risk Addiction, 2020. PubMed
Chayama KL, Ng C, McNeil R Calls for access to safe injecting supplies as a critical public health measure during the COVID-19 pandemic J Addict Med, 2020. PubMed
